MedTrace Logo

Embryo Selection Using Non-invasive Metabolomic Analysis Versus Morphology

NCT01490515 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2013-12-16

No results posted yet for this study

Summary

Metabolomics was recently introduced in human IVF for non-invasive identification of viable embryos with the highest developmental competence. The investigators intended to investigate if embryo assessment using non-invasive metabolomic profiling leads to increased implantation rates compared to routine morphology evaluation alone.

Conditions

  • Embryo Viability

Interventions

PROCEDURE

non-invasive metabolomic profiling

non-invasive metabolomic profiling of IVF human embryos

OTHER

morphological evaluation

Simple microscopic observation of embryos and evaluation of morphological characteristics

Sponsors & Collaborators

  • Eugonia

    lead OTHER

Principal Investigators

  • Ioannis Sfontouris, PhD · Eugonia

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01490515 on ClinicalTrials.gov